HEADER MEMBRANE PROTEIN 12-JUL-19 6PS2 TITLE XFEL BETA2 AR STRUCTURE BY LIGAND EXCHANGE FROM TIMOLOL TO ALPRENOLOL. COMPND MOL_ID: 1; COMPND 2 MOLECULE: FUSION PROTEIN OF BETA-2 ADRENERGIC RECEPTOR AND T4 COMPND 3 LYSOZYME; COMPND 4 CHAIN: A; COMPND 5 SYNONYM: BETA-2 ADRENORECEPTOR,BETA-2 ADRENOCEPTOR,LYSIS PROTEIN, COMPND 6 LYSOZYME,MURAMIDASE; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS, ENTEROBACTERIA PHAGE T4; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606, 10665; SOURCE 5 GENE: ADRB2, ADRB2R, B2AR, E, T4TP126; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS GPCR, COMPLEX-LCP METHOD, SBDD, DRUG DESIGN, XFEL, LCP-SFX, LIGAND KEYWDS 2 EXCHANGE, TIMOLOL, ALPRENOLOL, MEMBRANE PROTEIN, B2AR, BETA2AR EXPDTA X-RAY DIFFRACTION AUTHOR A.ISHCHENKO,B.STAUCH,G.W.HAN,A.BATYUK,A.SHIRIAEVA,C.LI,N.A.ZATSEPIN, AUTHOR 2 U.WEIERSTALL,W.LIU,E.NANGO,T.NAKANE,R.TANAKA,K.TONO,Y.JOTI,S.IWATA, AUTHOR 3 I.MORAES,C.GATI,C.CHEREZOV REVDAT 5 20-NOV-24 6PS2 1 REMARK REVDAT 4 11-OCT-23 6PS2 1 REMARK REVDAT 3 01-JAN-20 6PS2 1 REMARK REVDAT 2 25-DEC-19 6PS2 1 JRNL REVDAT 1 13-NOV-19 6PS2 0 JRNL AUTH A.ISHCHENKO,B.STAUCH,G.W.HAN,A.BATYUK,A.SHIRIAEVA,C.LI, JRNL AUTH 2 N.ZATSEPIN,U.WEIERSTALL,W.LIU,E.NANGO,T.NAKANE,R.TANAKA, JRNL AUTH 3 K.TONO,Y.JOTI,S.IWATA,I.MORAES,C.GATI,V.CHEREZOV JRNL TITL TOWARD G PROTEIN-COUPLED RECEPTOR STRUCTURE-BASED DRUG JRNL TITL 2 DESIGN USING X-RAY LASERS. JRNL REF IUCRJ V. 6 1106 2019 JRNL REFN ESSN 2052-2525 JRNL PMID 31709066 JRNL DOI 10.1107/S2052252519013137 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.10.2 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.82 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 22205 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.183 REMARK 3 R VALUE (WORKING SET) : 0.181 REMARK 3 FREE R VALUE : 0.224 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1110 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.000 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 11 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.52 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.34 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2864 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2490 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2722 REMARK 3 BIN R VALUE (WORKING SET) : 0.2470 REMARK 3 BIN FREE R VALUE : 0.2820 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.96 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 142 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3526 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 266 REMARK 3 SOLVENT ATOMS : 36 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 89.28 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -13.76220 REMARK 3 B22 (A**2) : 5.24280 REMARK 3 B33 (A**2) : 8.51950 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.360 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.331 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.222 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.330 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.224 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.956 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.944 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 3920 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 5291 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1832 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 72 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 562 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 3920 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 505 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 4779 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.03 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.64 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 3.28 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): 8.7183 3.6358 25.9184 REMARK 3 T TENSOR REMARK 3 T11: 0.0114 T22: -0.2651 REMARK 3 T33: -0.2750 T12: -0.0237 REMARK 3 T13: -0.0230 T23: 0.0355 REMARK 3 L TENSOR REMARK 3 L11: 0.8897 L22: 0.8853 REMARK 3 L33: 2.8863 L12: -0.4335 REMARK 3 L13: -0.8596 L23: 0.6668 REMARK 3 S TENSOR REMARK 3 S11: -0.0249 S12: 0.0024 S13: 0.0524 REMARK 3 S21: 0.1198 S22: -0.0148 S23: -0.0586 REMARK 3 S31: -0.2753 S32: 0.0889 S33: 0.0398 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6PS2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-JUL-19. REMARK 100 THE DEPOSITION ID IS D_1000242971. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-NOV-14 REMARK 200 TEMPERATURE (KELVIN) : 293 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : FREE ELECTRON LASER REMARK 200 BEAMLINE : CXI REMARK 200 X-RAY GENERATOR MODEL : SLAC LCLS BEAMLINE CXI REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.33 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : CS-PAD CXI-1 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : CRYSTFEL REMARK 200 DATA SCALING SOFTWARE : CRYSTFEL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22282 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 30.820 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 503.6 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.52 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3D4S REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.22 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.42 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M HEPES PH 7.0, 0.1 M AMMONIUM REMARK 280 SULFATE, 30% PEG 400, 2 MM OF TARGET LIGAND ALPRENOLOL, LIPIDIC REMARK 280 CUBIC PHASE, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 20.82500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 85.95000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 38.12000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 85.95000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 20.82500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 38.12000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: AUTHORS STATE THAT THE BIOLOGICAL UNIT IS UNKNOWN REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -23 REMARK 465 LYS A -22 REMARK 465 THR A -21 REMARK 465 ILE A -20 REMARK 465 ILE A -19 REMARK 465 ALA A -18 REMARK 465 LEU A -17 REMARK 465 SER A -16 REMARK 465 TYR A -15 REMARK 465 ILE A -14 REMARK 465 PHE A -13 REMARK 465 CYS A -12 REMARK 465 LEU A -11 REMARK 465 VAL A -10 REMARK 465 PHE A -9 REMARK 465 ALA A -8 REMARK 465 ASP A -7 REMARK 465 TYR A -6 REMARK 465 LYS A -5 REMARK 465 ASP A -4 REMARK 465 ASP A -3 REMARK 465 ASP A -2 REMARK 465 ASP A -1 REMARK 465 ALA A 0 REMARK 465 MET A 1 REMARK 465 GLY A 2 REMARK 465 GLN A 3 REMARK 465 PRO A 4 REMARK 465 GLY A 5 REMARK 465 ASN A 6 REMARK 465 GLY A 7 REMARK 465 SER A 8 REMARK 465 ALA A 9 REMARK 465 PHE A 10 REMARK 465 LEU A 11 REMARK 465 LEU A 12 REMARK 465 ALA A 13 REMARK 465 PRO A 14 REMARK 465 ASN A 15 REMARK 465 ARG A 16 REMARK 465 SER A 17 REMARK 465 HIS A 18 REMARK 465 ALA A 19 REMARK 465 PRO A 20 REMARK 465 ASP A 21 REMARK 465 HIS A 22 REMARK 465 ASP A 23 REMARK 465 VAL A 24 REMARK 465 THR A 25 REMARK 465 GLN A 26 REMARK 465 GLN A 27 REMARK 465 ARG A 343 REMARK 465 ARG A 344 REMARK 465 SER A 345 REMARK 465 SER A 346 REMARK 465 LEU A 347 REMARK 465 LYS A 348 REMARK 465 HIS A 349 REMARK 465 HIS A 350 REMARK 465 HIS A 351 REMARK 465 HIS A 352 REMARK 465 HIS A 353 REMARK 465 HIS A 354 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 28 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 60 CD CE NZ REMARK 470 LYS A 97 CE NZ REMARK 470 LYS A 227 CE NZ REMARK 470 LYS A1016 CG CD CE NZ REMARK 470 LYS A1019 CG CD CE NZ REMARK 470 LYS A1048 CD CE NZ REMARK 470 LYS A1060 CD CE NZ REMARK 470 ASP A1061 OD1 OD2 REMARK 470 LYS A 267 CG CD CE NZ REMARK 470 ILE A 303 CG1 CG2 CD1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 86 -71.25 -108.94 REMARK 500 LYS A 140 -61.78 62.31 REMARK 500 PHE A 208 -53.17 -131.58 REMARK 500 PRO A1037 34.67 -86.20 REMARK 500 ARG A1125 66.23 -100.27 REMARK 500 ASP A 300 -39.73 82.61 REMARK 500 LEU A 302 14.71 80.15 REMARK 500 ARG A 304 -162.66 63.04 REMARK 500 LYS A 305 -43.05 -130.69 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 OLB A 1203 REMARK 610 OLB A 1204 REMARK 610 OLB A 1205 REMARK 610 OLB A 1206 REMARK 610 OLB A 1207 REMARK 610 OLB A 1208 REMARK 610 OLC A 1209 REMARK 610 OLB A 1210 REMARK 610 OLC A 1215 REMARK 610 OLC A 1216 REMARK 610 OLA A 1217 REMARK 610 OLA A 1218 REMARK 610 OLA A 1219 REMARK 610 OLA A 1220 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue JTZ A 1201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CLR A 1202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLB A 1203 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLB A 1204 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLB A 1205 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLB A 1206 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLB A 1207 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLB A 1208 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLC A 1209 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLB A 1210 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 1211 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 1212 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 1213 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 1214 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLC A 1215 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLC A 1216 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLA A 1217 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLA A 1218 REMARK 800 REMARK 800 SITE_IDENTIFIER: AE1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLA A 1219 REMARK 800 REMARK 800 SITE_IDENTIFIER: AE2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLA A 1220 DBREF 6PS2 A 1 230 UNP P07550 ADRB2_HUMAN 1 230 DBREF 6PS2 A 1002 1161 UNP D9IEF7 D9IEF7_BPT4 2 161 DBREF 6PS2 A 263 348 UNP P07550 ADRB2_HUMAN 263 348 SEQADV 6PS2 MET A -23 UNP P07550 INITIATING METHIONINE SEQADV 6PS2 LYS A -22 UNP P07550 EXPRESSION TAG SEQADV 6PS2 THR A -21 UNP P07550 EXPRESSION TAG SEQADV 6PS2 ILE A -20 UNP P07550 EXPRESSION TAG SEQADV 6PS2 ILE A -19 UNP P07550 EXPRESSION TAG SEQADV 6PS2 ALA A -18 UNP P07550 EXPRESSION TAG SEQADV 6PS2 LEU A -17 UNP P07550 EXPRESSION TAG SEQADV 6PS2 SER A -16 UNP P07550 EXPRESSION TAG SEQADV 6PS2 TYR A -15 UNP P07550 EXPRESSION TAG SEQADV 6PS2 ILE A -14 UNP P07550 EXPRESSION TAG SEQADV 6PS2 PHE A -13 UNP P07550 EXPRESSION TAG SEQADV 6PS2 CYS A -12 UNP P07550 EXPRESSION TAG SEQADV 6PS2 LEU A -11 UNP P07550 EXPRESSION TAG SEQADV 6PS2 VAL A -10 UNP P07550 EXPRESSION TAG SEQADV 6PS2 PHE A -9 UNP P07550 EXPRESSION TAG SEQADV 6PS2 ALA A -8 UNP P07550 EXPRESSION TAG SEQADV 6PS2 ASP A -7 UNP P07550 EXPRESSION TAG SEQADV 6PS2 TYR A -6 UNP P07550 EXPRESSION TAG SEQADV 6PS2 LYS A -5 UNP P07550 EXPRESSION TAG SEQADV 6PS2 ASP A -4 UNP P07550 EXPRESSION TAG SEQADV 6PS2 ASP A -3 UNP P07550 EXPRESSION TAG SEQADV 6PS2 ASP A -2 UNP P07550 EXPRESSION TAG SEQADV 6PS2 ASP A -1 UNP P07550 EXPRESSION TAG SEQADV 6PS2 ALA A 0 UNP P07550 EXPRESSION TAG SEQADV 6PS2 ARG A 16 UNP P07550 GLY 16 VARIANT SEQADV 6PS2 GLN A 27 UNP P07550 GLU 27 VARIANT SEQADV 6PS2 TRP A 122 UNP P07550 GLU 122 ENGINEERED MUTATION SEQADV 6PS2 GLU A 187 UNP P07550 ASN 187 ENGINEERED MUTATION SEQADV 6PS2 THR A 1054 UNP D9IEF7 CYS 54 ENGINEERED MUTATION SEQADV 6PS2 ALA A 1097 UNP D9IEF7 CYS 97 ENGINEERED MUTATION SEQADV 6PS2 HIS A 349 UNP P07550 EXPRESSION TAG SEQADV 6PS2 HIS A 350 UNP P07550 EXPRESSION TAG SEQADV 6PS2 HIS A 351 UNP P07550 EXPRESSION TAG SEQADV 6PS2 HIS A 352 UNP P07550 EXPRESSION TAG SEQADV 6PS2 HIS A 353 UNP P07550 EXPRESSION TAG SEQADV 6PS2 HIS A 354 UNP P07550 EXPRESSION TAG SEQRES 1 A 506 MET LYS THR ILE ILE ALA LEU SER TYR ILE PHE CYS LEU SEQRES 2 A 506 VAL PHE ALA ASP TYR LYS ASP ASP ASP ASP ALA MET GLY SEQRES 3 A 506 GLN PRO GLY ASN GLY SER ALA PHE LEU LEU ALA PRO ASN SEQRES 4 A 506 ARG SER HIS ALA PRO ASP HIS ASP VAL THR GLN GLN ARG SEQRES 5 A 506 ASP GLU VAL TRP VAL VAL GLY MET GLY ILE VAL MET SER SEQRES 6 A 506 LEU ILE VAL LEU ALA ILE VAL PHE GLY ASN VAL LEU VAL SEQRES 7 A 506 ILE THR ALA ILE ALA LYS PHE GLU ARG LEU GLN THR VAL SEQRES 8 A 506 THR ASN TYR PHE ILE THR SER LEU ALA CYS ALA ASP LEU SEQRES 9 A 506 VAL MET GLY LEU ALA VAL VAL PRO PHE GLY ALA ALA HIS SEQRES 10 A 506 ILE LEU MET LYS MET TRP THR PHE GLY ASN PHE TRP CYS SEQRES 11 A 506 GLU PHE TRP THR SER ILE ASP VAL LEU CYS VAL THR ALA SEQRES 12 A 506 SER ILE TRP THR LEU CYS VAL ILE ALA VAL ASP ARG TYR SEQRES 13 A 506 PHE ALA ILE THR SER PRO PHE LYS TYR GLN SER LEU LEU SEQRES 14 A 506 THR LYS ASN LYS ALA ARG VAL ILE ILE LEU MET VAL TRP SEQRES 15 A 506 ILE VAL SER GLY LEU THR SER PHE LEU PRO ILE GLN MET SEQRES 16 A 506 HIS TRP TYR ARG ALA THR HIS GLN GLU ALA ILE ASN CYS SEQRES 17 A 506 TYR ALA GLU GLU THR CYS CYS ASP PHE PHE THR ASN GLN SEQRES 18 A 506 ALA TYR ALA ILE ALA SER SER ILE VAL SER PHE TYR VAL SEQRES 19 A 506 PRO LEU VAL ILE MET VAL PHE VAL TYR SER ARG VAL PHE SEQRES 20 A 506 GLN GLU ALA LYS ARG GLN LEU ASN ILE PHE GLU MET LEU SEQRES 21 A 506 ARG ILE ASP GLU GLY LEU ARG LEU LYS ILE TYR LYS ASP SEQRES 22 A 506 THR GLU GLY TYR TYR THR ILE GLY ILE GLY HIS LEU LEU SEQRES 23 A 506 THR LYS SER PRO SER LEU ASN ALA ALA LYS SER GLU LEU SEQRES 24 A 506 ASP LYS ALA ILE GLY ARG ASN THR ASN GLY VAL ILE THR SEQRES 25 A 506 LYS ASP GLU ALA GLU LYS LEU PHE ASN GLN ASP VAL ASP SEQRES 26 A 506 ALA ALA VAL ARG GLY ILE LEU ARG ASN ALA LYS LEU LYS SEQRES 27 A 506 PRO VAL TYR ASP SER LEU ASP ALA VAL ARG ARG ALA ALA SEQRES 28 A 506 LEU ILE ASN MET VAL PHE GLN MET GLY GLU THR GLY VAL SEQRES 29 A 506 ALA GLY PHE THR ASN SER LEU ARG MET LEU GLN GLN LYS SEQRES 30 A 506 ARG TRP ASP GLU ALA ALA VAL ASN LEU ALA LYS SER ARG SEQRES 31 A 506 TRP TYR ASN GLN THR PRO ASN ARG ALA LYS ARG VAL ILE SEQRES 32 A 506 THR THR PHE ARG THR GLY THR TRP ASP ALA TYR LYS PHE SEQRES 33 A 506 CYS LEU LYS GLU HIS LYS ALA LEU LYS THR LEU GLY ILE SEQRES 34 A 506 ILE MET GLY THR PHE THR LEU CYS TRP LEU PRO PHE PHE SEQRES 35 A 506 ILE VAL ASN ILE VAL HIS VAL ILE GLN ASP ASN LEU ILE SEQRES 36 A 506 ARG LYS GLU VAL TYR ILE LEU LEU ASN TRP ILE GLY TYR SEQRES 37 A 506 VAL ASN SER GLY PHE ASN PRO LEU ILE TYR CYS ARG SER SEQRES 38 A 506 PRO ASP PHE ARG ILE ALA PHE GLN GLU LEU LEU CYS LEU SEQRES 39 A 506 ARG ARG SER SER LEU LYS HIS HIS HIS HIS HIS HIS HET JTZ A1201 18 HET CLR A1202 28 HET OLB A1203 18 HET OLB A1204 12 HET OLB A1205 15 HET OLB A1206 13 HET OLB A1207 13 HET OLB A1208 13 HET OLC A1209 10 HET OLB A1210 18 HET SO4 A1211 5 HET SO4 A1212 5 HET SO4 A1213 5 HET SO4 A1214 5 HET OLC A1215 16 HET OLC A1216 21 HET OLA A1217 14 HET OLA A1218 14 HET OLA A1219 10 HET OLA A1220 13 HETNAM JTZ (2S)-1-[(1-METHYLETHYL)AMINO]-3-(2-PROP-2-EN-1- HETNAM 2 JTZ YLPHENOXY)PROPAN-2-OL HETNAM CLR CHOLESTEROL HETNAM OLB (2S)-2,3-DIHYDROXYPROPYL (9Z)-OCTADEC-9-ENOATE HETNAM OLC (2R)-2,3-DIHYDROXYPROPYL (9Z)-OCTADEC-9-ENOATE HETNAM SO4 SULFATE ION HETNAM OLA OLEIC ACID HETSYN OLC 1-OLEOYL-R-GLYCEROL FORMUL 2 JTZ C15 H23 N O2 FORMUL 3 CLR C27 H46 O FORMUL 4 OLB 7(C21 H40 O4) FORMUL 10 OLC 3(C21 H40 O4) FORMUL 12 SO4 4(O4 S 2-) FORMUL 18 OLA 4(C18 H34 O2) FORMUL 22 HOH *36(H2 O) HELIX 1 AA1 ASP A 29 PHE A 61 1 33 HELIX 2 AA2 GLU A 62 GLN A 65 5 4 HELIX 3 AA3 THR A 66 VAL A 86 1 21 HELIX 4 AA4 VAL A 86 MET A 96 1 11 HELIX 5 AA5 PHE A 101 THR A 136 1 36 HELIX 6 AA6 THR A 146 MET A 171 1 26 HELIX 7 AA7 HIS A 178 GLU A 187 1 10 HELIX 8 AA8 ASN A 196 PHE A 208 1 13 HELIX 9 AA9 PHE A 208 GLN A 229 1 22 HELIX 10 AB1 ASN A 1002 GLY A 1012 1 11 HELIX 11 AB2 SER A 1038 GLY A 1051 1 14 HELIX 12 AB3 THR A 1059 ASN A 1081 1 23 HELIX 13 AB4 LEU A 1084 LEU A 1091 1 8 HELIX 14 AB5 ASP A 1092 GLY A 1107 1 16 HELIX 15 AB6 GLY A 1107 ALA A 1112 1 6 HELIX 16 AB7 PHE A 1114 GLN A 1123 1 10 HELIX 17 AB8 ARG A 1125 LYS A 1135 1 11 HELIX 18 AB9 SER A 1136 THR A 1142 1 7 HELIX 19 AC1 THR A 1142 GLY A 1156 1 15 HELIX 20 AC2 LEU A 266 GLN A 299 1 34 HELIX 21 AC3 LYS A 305 ASN A 318 1 14 HELIX 22 AC4 PHE A 321 TYR A 326 1 6 HELIX 23 AC5 SER A 329 LEU A 340 1 12 SHEET 1 AA1 3 ARG A1014 LYS A1019 0 SHEET 2 AA1 3 TYR A1025 GLY A1028 -1 O THR A1026 N TYR A1018 SHEET 3 AA1 3 HIS A1031 THR A1034 -1 O LEU A1033 N TYR A1025 SSBOND 1 CYS A 106 CYS A 191 1555 1555 2.03 SSBOND 2 CYS A 184 CYS A 190 1555 1555 2.03 SITE 1 AC1 10 THR A 110 ASP A 113 PHE A 193 SER A 203 SITE 2 AC1 10 SER A 207 TRP A 286 PHE A 289 PHE A 290 SITE 3 AC1 10 ASN A 293 ASN A 312 SITE 1 AC2 5 TYR A 70 CYS A 77 ILE A 154 TRP A 158 SITE 2 AC2 5 OLC A1215 SITE 1 AC3 2 ALA A 59 LYS A 60 SITE 1 AC4 6 PHE A 89 PHE A 101 TRP A 105 PHE A 217 SITE 2 AC4 6 OLA A1219 HOH A1313 SITE 1 AC5 7 VAL A 126 ASP A 130 PHE A 133 LEU A 144 SITE 2 AC5 7 LEU A 145 OLB A1210 HOH A1319 SITE 1 AC6 4 LYS A 273 GLY A 276 GLY A 280 OLA A1220 SITE 1 AC7 3 TRP A 173 ASN A 196 LEU A 340 SITE 1 AC8 3 CYS A 327 GLN A 337 LEU A 342 SITE 1 AC9 3 TRP A 122 VAL A 160 SER A 161 SITE 1 AD1 5 SER A 41 LEU A 95 PHE A 133 OLB A1205 SITE 2 AD1 5 OLA A1219 SITE 1 AD2 6 VAL A 67 THR A 68 ARG A 131 TYR A 141 SITE 2 AD2 6 GLN A 142 SER A 143 SITE 1 AD3 3 LYS A 270 LYS A 273 ARG A 328 SITE 1 AD4 5 PHE A1114 THR A1115 ASN A1116 SER A1117 SITE 2 AD4 5 ASN A1132 SITE 1 AD5 4 THR A1142 PRO A1143 ASN A1144 ARG A1145 SITE 1 AD6 3 ILE A 55 THR A 73 CLR A1202 SITE 1 AD7 4 PHE A 49 GLN A 197 LEU A 339 OLA A1218 SITE 1 AD8 1 ILE A 314 SITE 1 AD9 3 THR A 56 ILE A 298 OLC A1216 SITE 1 AE1 5 THR A 100 PHE A 217 ARG A 221 OLB A1204 SITE 2 AE1 5 OLB A1210 SITE 1 AE2 3 VAL A 216 PHE A 223 OLB A1206 CRYST1 41.650 76.240 171.900 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.024010 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013116 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005817 0.00000